Insider trades

Marcus Schulz, CRO of Biolife Solutions BLFS, has filed 0 purchases and 16 sales on the open market. The latest trade was on 23/08/25.

Marcus Schulz

Chief Revenue Officer
First filing
23/01/12
Trades
20 trades
Buys / sales
0 / 16
12-month net buying
No record
Last trade
23/08/25

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan23/08/2523/08/29347 sh$10.99$3,813.53−0.8%
Open-market sale10b5-1 plan23/08/1423/08/16108 sh$12.38$1,337.04−0.3%
Open-market sale10b5-1 plan23/07/2423/07/26679 sh$19.50$13,240.5−1.6%
Open-market sale10b5-1 plan23/07/1123/07/13331 sh$22.79$7,543.49−0.8%
Open-market sale10b5-1 plan23/05/3123/06/02337 sh$23.21$7,821.77−0.8%
Open-market sale10b5-1 plan23/05/1523/05/1775 sh$18.71$1,403.25−0.2%
Open-market sale10b5-1 plan · Amendment23/04/0623/05/16771 sh$20.03$15,443.13−1.7%
Open-market sale10b5-1 plan23/04/1923/04/21430 sh$19.33$8,311.9−1.0%
Open-market sale10b5-1 plan23/04/1423/04/18215 sh$21.05$4,525.75−0.5%
Open-market sale23/04/0623/04/10771 sh$20.03$15,443.13−1.8%
Open-market sale23/03/0123/03/03903 sh$22.75$20,543.25−2.1%
Open-market sale23/02/0923/02/1356 sh$24.60$1,377.6−0.1%
Open-market sale23/01/2323/01/251,000 sh$25.02$25,020−2.3%
BLFS
Open-market sale23/01/18–23/01/1923/01/203,538 sh2 trades$24.72avg.$87,456.34−7.4%
Open-market sale23/01/1123/01/12258 sh$21.94$5,660.52−0.5%